A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia Applicable to Patients Treated with Novel Therapies and Standard of Care

BRITISH JOURNAL OF HAEMATOLOGY(2018)

引用 0|浏览18
暂无评分
摘要
Introduction:
更多
查看译文
关键词
Chronic Lymphocytic Leukaemia,CLL,idelalisib,Risk Model
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要